Cargando…

Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer death worldwide with a minority of patients being diagnosed early enough for curative-intent interventions. We report the first use of preoperative cabozantinib plus nivolumab to successfully downstage what presented as unresectabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Won Jin, Sharma, Gaurav, Zhu, Qingfeng, Stein-O'Brien, Genevieve, Durham, Jennifer, Anders, Robert, Popovic, Aleksandra, Mo, Guanglan, Kamel, Ihab, Weiss, Matthew, Jaffee, Elizabeth, Fertig, Elana J, Yarchoan, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682468/ https://www.ncbi.nlm.nih.gov/pubmed/33219090 http://dx.doi.org/10.1136/jitc-2020-000932

Ejemplares similares

Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
por: Ho, Won Jin, et al.
Publicado: (2021)

Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence
por: Zhang, Shuming, et al.
Publicado: (2023)

Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence
por: Zhang, Shuming, et al.
Publicado: (2023)

Informing virtual clinical trials of hepatocellular carcinoma with spatial multi-omics analysis of a human neoadjuvant immunotherapy clinical trial
por: Zhang, Shuming, et al.
Publicado: (2023)

Transcriptomic forecasting with neural ordinary differential equations
por: Erbe, Rossin, et al.
Publicado: (2023)

Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma
por: Ho, Won Jin, et al.
Publicado: (2020)

Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trials
por: Sidiropoulos, Dimitrios N., et al.
Publicado: (2022)

Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade
por: Shu, Daniel H., et al.
Publicado: (2023)

Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
por: Li, Keyu, et al.
Publicado: (2022)

Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways
por: Ho, Won Jin, et al.
Publicado: (2021)

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy
por: Bigelow, Emma, et al.
Publicado: (2022)

Advances in Computational Immunology
por: Pappalardo, Francesco, et al.
Publicado: (2015)

Epigenetic regulation of gene expression in cancer: techniques, resources and analysis
por: Kagohara, Luciane T, et al.
Publicado: (2017)

A Mentee’s Baby Registry: Supporting New Academic Parents in 2020
por: Fertig, Elana J.
Publicado: (2020)

Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
por: Chen, Krista Y., et al.
Publicado: (2022)

Enter the Matrix: Factorization Uncovers Knowledge from Omics
por: Stein-O’Brien, Genevieve L., et al.
Publicado: (2018)

Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors
por: Davis-Marcisak, Emily F., et al.
Publicado: (2021)

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma
por: Jafarnejad, Mohammad, et al.
Publicado: (2019)

Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors
por: Diehl, Adam, et al.
Publicado: (2017)

Quantifying the Dynamics of Coupled Networks of Switches and Oscillators
por: Francis, Matthew R., et al.
Publicado: (2012)

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer
por: Mi, Haoyang, et al.
Publicado: (2020)

Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity
por: Predina, Jarrod D., et al.
Publicado: (2021)

shinyMethyl: interactive quality control of Illumina 450k DNA methylation arrays in R
por: Fortin, Jean-Philippe, et al.
Publicado: (2014)

Learning Dysregulated Pathways in Cancers from Differential Variability Analysis
por: Afsari, Bahman, et al.
Publicado: (2014)

Generating colorblind-friendly scatter plots for single-cell data
por: Guha, Tejas, et al.
Publicado: (2022)

CancerInSilico: An R/Bioconductor package for combining mathematical and statistical modeling to simulate time course bulk and single cell gene expression data in cancer
por: Sherman, Thomas D., et al.
Publicado: (2019)

Intralipid Therapy for Inadvertent Peripheral Nervous System Blockade Resulting from Local Anesthetic Overdose
por: Kamel, Ihab, et al.
Publicado: (2015)

Conversion Surgery for Pancreatic Cancer—The Impact of Neoadjuvant Treatment
por: Klaiber, Ulla, et al.
Publicado: (2020)

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
por: Chan, T A, et al.
Publicado: (2019)

Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic
por: Jia, Angela Y., et al.
Publicado: (2021)

CoGAPS 3: Bayesian non-negative matrix factorization for single-cell analysis with asynchronous updates and sparse data structures
por: Sherman, Thomas D., et al.
Publicado: (2020)

Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma
por: Deng, Chuangzhong, et al.
Publicado: (2020)

Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance
por: Stein-O’Brien, Genevieve, et al.
Publicado: (2018)

CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network
por: Fertig, Elana J., et al.
Publicado: (2016)

Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
por: Zhao, Hai-Tao, et al.
Publicado: (2021)

Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications
por: Angstadt, Shantel, et al.
Publicado: (2022)

Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes
por: Fertig, Elana J., et al.
Publicado: (2015)

DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
por: Qu, Jinrong, et al.
Publicado: (2022)

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma
por: Heumann, Thatcher, et al.
Publicado: (2023)

Serial Testing for Tuberculosis: Can We Make Sense of T Cell Assay Conversions and Reversions?
por: Pai, Madhukar, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_nm43ssniac1q9ph1e90shhnt8e